Author: Mathew, Divij; Giles, Josephine R.; Baxter, Amy E.; Greenplate, Allison R.; Wu, Jennifer E.; Alanio, Cécile; Oldridge, Derek A.; Kuri-Cervantes, Leticia; Pampena, M. Betina; D’Andrea, Kurt; Manne, Sasikanth; Chen, Zeyu; Huang, Yinghui Jane; Reilly, John P.; Weisman, Ariel R,; Ittner, Caroline A.G.; Kuthuru, Oliva; Dougherty, Jeanette; Nzingha, Kito; Han, Nicholas; Kim, Justin; Pattekar, Ajinkya; Goodwin, Eileen C.; Anderson, Elizabeth M.; Weirick, Madison E.; Gouma, Sigrid; Arevalo, Claudia P.; Bolton, Marcus J.; Chen, Fang; Lacey, Simon F.; Hensley, Scott E.; Apostolidis, Sokratis; Huang, Alexander C.; Vella, Laura A.; Betts, Michael R.; Meyer, Nuala J.; Wherry, E. John
Title: Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions Cord-id: wcmxmahq Document date: 2020_5_23
ID: wcmxmahq
Snippet: COVID-19 has become a global pandemic. Immune dysregulation has been implicated, but immune responses remain poorly understood. We analyzed 71 COVID-19 patients compared to recovered and healthy subjects using high dimensional cytometry. Integrated analysis of ~200 immune and >30 clinical features revealed activation of T cell and B cell subsets, but only in some patients. A subgroup of patients had T cell activation characteristic of acute viral infection and plasmablast responses could reach >
Document: COVID-19 has become a global pandemic. Immune dysregulation has been implicated, but immune responses remain poorly understood. We analyzed 71 COVID-19 patients compared to recovered and healthy subjects using high dimensional cytometry. Integrated analysis of ~200 immune and >30 clinical features revealed activation of T cell and B cell subsets, but only in some patients. A subgroup of patients had T cell activation characteristic of acute viral infection and plasmablast responses could reach >30% of circulating B cells. However, another subgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change. These analyses identified three “immunotypes†associated with poor clinical trajectories versus improving health. These immunotypes may have implications for therapeutics and vaccines.
Search related documents:
Co phrase search for related documents- absolute count and acute ards respiratory distress syndrome: 1, 2, 3, 4
- absolute count and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation marker and acute ards respiratory distress syndrome: 1, 2
- activation marker and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- activation marker expression and acute ards respiratory distress syndrome: 1, 2
- activation marker expression and acute infection: 1, 2, 3, 4, 5, 6, 7
- activation phenotype and acute ards respiratory distress syndrome: 1, 2, 3
- activation phenotype and acute infection: 1, 2, 3, 4, 5
- activation proliferation and acute ards respiratory distress syndrome: 1, 2
- activation proliferation and acute infection: 1, 2, 3, 4, 5
- activation state and acute ards respiratory distress syndrome: 1, 2
- activation state and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date